Filing Details

Accession Number:
0001209191-22-031236
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-23 06:09:42
Reporting Period:
2022-05-19
Accepted Time:
2022-05-23 06:09:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1574094 Renovorx Inc. RNXT Pharmaceutical Preparations (2834) 271448452
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1862613 Shaun Bagai C/O Renovorx, Inc.
4546 El Camino Real, Suite B1
Los Altos CA 94022
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-19 5,500 $2.05 251,557 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering.